Hygeia
Hygeia is a oncology healthcare company.
Hygeia, founded in 2009 and headquartered in Shanghai, is a provider of oncology medical services. The founder is Zhu Yiwen. Listed on the Hong Kong Stock Exchange on June 29, 2020, the company’s major shareholders are Harmony Healthcare and Fountain Grass. Rivals that have direct and indirect competition with Hygeia include Kangji Medical Holdings Limited, Gan&Lee Pharmaceuticals, Immunotech Biopharm Ltd..
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
East China medicine "liraglutide" goes to sea
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
Huashen Zhiyao completed nearly 500million yuan of a-round financing and went deep into AI new drug development
CelcomDigi Berhad and AmBank Sign MOU to Drive Digital Healthcare Transformation
CelcomDigi Berhad today announced the signing of a three-year Memorandum of Understanding (MoU) with AmBank (M) Berhad and AmBank Islamic Berhad, with the aim of empowering healthcare providers in Malaysia through digital healthcare solutions.
Oct 29, 2024 05:36 PM
SINOVAC Plans to Invest USD 100 Mn in Brazil Starting This Year
EqualOcean has learned that on June 4, Vice President of the Federative Republic of Brazil and Minister of Development, Industry, Trade, and Services, Geraldo Alckmin, met with SINOVAC(科兴) Chairman, President, and CEO Yin Weidong(尹卫东) in Beijing.
Jun 06, 2024 06:18 PM
Huamei Haolian, a health management service enterprise, completed round a+ financing, and Jinshajiang venture capital led the investment
Mojia biology announced the completion of round B financing
First class recall of Draeger, a ventilator giant
Hong Kong Pharmaceutical stocks plunged straight in the afternoon